Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-278-6 | CAS number: 118-79-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: dermal
Administrative data
- Endpoint:
- short-term repeated dose toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other:
- Remarks:
- This study does not meet the detail requirements for current guidelines, but the study design was adequate to produce results that are acceptable for assessment. The design included three doses, abraded and unabraded skin, sufficient males and females, monitoring of weight, hematology, blood chemistry, urinalysis, and gross and microscopic pathology.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 977
- Report date:
- 1977
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Young adult male and female albino rabbits had the hair on their backs removed with clippers, and were allowed to recover for 24 hours. The animals were divided into groups of 4 of each sex per dose, and 2 additionally had their skin abraded after hair removal (as deep as the stratum corneum) with the tip of a needle prior to application of the test compound. The hair was clipped again at least once per week, and if applicable, the skin re-abraded twice per week. The rabbits were fitted with flexible plastic collars to prevent oral ingestion of the test compound from their unoccluded skin. The test compound was applied to the skin surface 5 days per week for 4 weeks at doses of 100, 300, and 1000 mg/kg, and the dose was distributed over 5-20% of the body surface of the animal. The test compound was not removed by washing or rinsing. Control animals received applications of 1% w/v aqueous methylcellulose vehicle.
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- 2,4,6-tribromophenol
- EC Number:
- 204-278-6
- EC Name:
- 2,4,6-tribromophenol
- Cas Number:
- 118-79-6
- Molecular formula:
- C6H3Br3O
- IUPAC Name:
- 2,4,6-tribromophenol
- Test material form:
- solid: granular
Constituent 1
- Specific details on test material used for the study:
- Lot number: 3106
Test animals
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
Administration / exposure
- Type of coverage:
- open
- Vehicle:
- other: aqueous methyl cellulose
- Details on exposure:
- TEST SITE
- Area of exposure: skin of the back
- % coverage: the clipped area was 30% of the total body surfacer; 5-20% of the body surface was contacted during the dermal application of test compound; clipping was reeated at least once per week, or more often if necessary; a 24-hour recovery period was allowed prior to application so skin could recover from the slight distrubance of the stratum corneum
- Time intervals for shavings or clipplings: Animals were clipped at least once per week
REMOVAL OF TEST SUBSTANCE
- Time after start of exposure: The study was conducted for four weeks, and the test compound was not removed during that time. The animals were unable to clean themselves because of a plastic collar to prevent ingestion of test compound, so they also did not remove the compound from the skin surface.
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): the 100 mg/kg dose was applied in 0.2 ml/kg; the 300 mg/kg dose was applied in 0.6 ml/kg; the 1000 mg/kg dose was applied in 2.0 ml/kg.
- Concentration (if solution): 50% w/v
- Constant volume or concentration used: constant concentration
- For solids, paste formed: as a 'suspension'
VEHICLE
- Justification for use and choice of vehicle (if other than water): aqueous methylcellulose
- Amount(s) applied (volume or weight with unit): 1% (w/v) - Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 5 days per week for 4 weeks; no removal of test compound between dosing
- Frequency of treatment:
- 5 times per week
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Dose / conc.:
- 100 mg/kg bw/day (nominal)
- Dose / conc.:
- 300 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 4 animals per sex per dose; 2 from each group had hair clipped from skin, while the remaining 2 had hair clipped and additional abrasion by a needle
- Control animals:
- yes, concurrent vehicle
- Positive control:
- no
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily
DETAILED CLINICAL OBSERVATIONS: No data
DERMAL IRRITATION (if dermal study): Yes
- Time schedule for examinations: after 1-3, 4, 9, 10-11, 16, 18, and 20th applications
BODY WEIGHT: Yes
- Time schedule for examinations: weekly, starting two weeks before dosing
HAEMATOLOGY: Yes
- Time schedule for collection of blood: Day -6 and Day 28
- Anaesthetic used for blood collection: No data
- Animals fasted: No data
- How many animals: 32 total
- Parameters checked in table [No.?] were examined: total leukocyte count, erythrocyte concentration, hemoglobin concentration, hematocrit value, differential leukocyte count
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: Day -6 and Day 28
- Animals fasted: Yes
- How many animals: 32
- Parameters checked in table [No.?] were examined: fasting blood glucose concentration, blood urea nitrogen concentration, serum alkaline phosphatase activity, serum glutamic pyruvic transaminase activity, serum glutamic oxalecetic transaminase activity
URINALYSIS: Yes
- Time schedule for collection of urine: Day -6 and Day 28
- Metabolism cages used for collection of urine: Yes
- Animals fasted: Yes
- Parameters checked in table [No.?] were examined: protein, glucose, ketones, occult blood, bilirubin, bile pigments, pH, RBC, WBC, crystals, casts, epithelial cells, specific gravity - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes (including organ weights)
HISTOPATHOLOGY: Yes
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- one rabbit died at 21 days, but cause of death was not evident from tissues examined
- Dermal irritation:
- effects observed, treatment-related
- Description (incidence and severity):
- slightly irritating
- Mortality:
- no mortality observed
- Description (incidence):
- one rabbit died at 21 days, but cause of death was not evident from tissues examined
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- no effects observed
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- epithelial acanthoses with hyperkeratosis (skin)
- Histopathological findings: neoplastic:
- no effects observed
- Description (incidence and severity):
- No treatment-related effects other than slight skin irritation reflected in epithelial acanthoses with hyperkeratosis.
Effect levels
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No pharmacotoxic symptoms were observed at any time during the study. Treatment-related lesions were noted on the test skin sites of all animals.
Target system / organ toxicity
- Critical effects observed:
- no
Applicant's summary and conclusion
- Conclusions:
- In this adequate 28-day dermal study, 2,4,6-tribromophenol was found to be slightly irritating to the skin, and no other indications of toxicity were found.
The NOAEL for subacute dermal toxicity of 2,4,6 -tribromophenol is 1000 mg/kg based on a lack of toxic effects at the highest dose tested in this study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.